What DEVEA SAS does

DEVEA SAS, founded in 2009 and headquartered in Saint-Étienne-de-Montluc, France, is a privately held specialist in Airborne Surface Disinfection (DSVA/ASD) using hydrogen peroxide. The company designs, manufactures, and supports the Phileas® device family — centrifugation-based diffusion units that generate 5–10 μm micro-droplets (its patented MicroDrop Technology) with a 180° dispersion pattern, paired with proprietary low-concentration (7.4%) H2O2 biocides (O2SAFE, Phileasafe). Its portfolio spans five ranges (EASY, OPTIMUM, CONTROL, INSIDE, BIOCIDE), addressing volumes from under 1 m³ isolators to 1,665 m³ rooms, and is complemented by the MyPhileas traceability application compliant with 21 CFR Part 11 and EU GMP Annex 11.

DEVEA monetizes through a quote-based enterprise model combining hardware sales (devices and consumables), recurring biocide consumption, and a growing services layer — on-site bio-decontamination, IQ/OQ/PQ qualifications, preventive maintenance, and warranty support on multi-year contracts. It sells primarily into pharmaceutical manufacturers, research laboratories (including BSL-3), hospitals and clinics, medical device makers, and food and cosmetics producers, with named customers such as Sanofi, Eli Lilly, Boehringer Ingelheim, Cipla, B. Braun, L'Oréal, Lactalis, AP-HP and the UK NHS. Distribution is direct for large French accounts and channel-partner-led internationally (Korea, Italy, Belgium, Algeria) across 30+ countries, reinforced by ISO 9001:2015 certification and the first French Marketing Authorization for a DSVA biocide (FR-2019-0071).

Name

DEVEA SAS

Legal name

DEVEA SAS

Website

https://devea-environnement.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

1–10 employees

Short description

DEVEA SAS is a French specialist in airborne surface disinfection (DSVA), designing, manufacturing, and servicing the patented MicroDrop Phileas® device family and 7.4% H2O2 biocides for pharmaceutical, research, healthcare, food, and cosmetics customers worldwide.

Ownership category

akta.pro rank

Product category

Industrial bio-decontamination equipment (airborne surface disinfection devices)

NAICS

Soap and Cleaning Compound Manufacturing (32561), Industrial and Commercial Fan and Blower and Air Purification Equipment Manufacturing (333413)

SIC

Specialty Cleaning, Polishing And Sanitation Preparations (2842), Chemicals & Allied Products (2800)

akta.pro primary industry

Disinfection & Surface Decontamination (Wipes, Sprays, Fogging, UV Robots) (HLAHANAD)

akta.pro secondary industries

Biohazard Spill Response & Decontamination Services (BPALAGAH), Concentrated Surface Disinfectants (Dilutable Liquids) (CRAJANAB)

Keywords

• Airborne surface disinfection
• Hydrogen peroxide disinfection
• Bio-decontamination equipment
• Cleanroom decontamination systems
• Pharmaceutical disinfection devices

Headquarters

HQ city

Cholet

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Phileas Device Sales: Sale of Phileas DSVA equipment devices across multiple product ranges (EASY, OPTIMUM, CONTROL, INSIDE) with varying capacity and integration options for different room volumes and environments.
2. Biocide Solutions: Sale of proprietary biocide solutions (Phileasafe and O2SAFE 7.4) that are compliant with EN 17-272 and carry Marketing Authorization FR-2019-0071.
3. Bio-decontamination Services: On-site bio-decontamination service provision where Devea prepares with clients and carries out DSVA operations, including 6-log service provisions in large volumes.
4. Qualification and Validation Services: IQ, OQ, PQ qualification services and personalized project support for DSVA implementation in various industry sectors.
5. Maintenance and After-Sales Services: Preventive maintenance services, warranty support, and after-sales service for Phileas equipment with one-year guarantee.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

DEVEA SAS designs, manufactures and services the Phileas® family of Airborne Surface Disinfection (DSVA/ASD) devices, using its proprietary MicroDrop centrifugation technology to diffuse ultra-fine 7.4% hydrogen peroxide micro-droplets for automated, reproducible bio-decontamination of cleanrooms, isolators, RABS and airlocks. The portfolio includes four device ranges (EASY, OPTIMUM, CONTROL, INSIDE), EN 17-272 compliant biocide consumables (Phileasafe and O2SAFE 7.4), the MyPhileas traceability application, and integrated services for qualification, bio-decontamination, and preventive maintenance aimed at pharmaceutical, biotechnology, healthcare, research and food industry customers.

Product overview

DEVEA SAS offers a comprehensive portfolio of Airborne Surface Disinfection (ASD/DSVA) solutions built around the patented Phileas® device family and proprietary MicroDrop Technology. The product ecosystem spans five distinct ranges: EASY (Phileas 5, 15, 25, One, 285) for entry-level to high-volume mobile applications; OPTIMUM (Phileas Genius, 75, 250) designed for demanding GMP pharmaceutical environments with enhanced traceability and user experience; CONTROL (Phileas Control, Control²) providing maximum safety and BMS integration for classified production areas; INSIDE (Phileas Airlock, ISO) offering integrated solutions for airlocks and isolators; and BIOCIDE (Phileasafe, O2SAFE 7.4) providing compliant disinfectant solutions. All devices utilize centrifugation-based ultra-fine mist diffusion (5-10µm micro-droplets) of low-concentration hydrogen peroxide (7.4%) for automated, reproducible surface decontamination. The offering is complemented by the MyPhileas traceability application and comprehensive services including bio-decontamination service provision, IQ/OQ/PQ qualifications, and preventive maintenance.

Differentiator

Problem solved

Functional benefit

Brands

• Phileas: Phileas® product range - hydrogen peroxide fog diffusion devices for airborne surface disinfection, including models 5, 15, 25, 75, 250, 285, Genius, Control, Control², Airlock, and ISO
• O2SAFE
• Phileasafe
• MyPhileas
• MicroDrop Technology

Products and services

• Phileas 5 DSVA Device Compact, integrated and mobile DSVA device for treating very small volumes (50 to 1000L) in pharmaceutical, laboratory and biotechnology environments; part of the Phileas® EASY range.
• Phileas 25 DSVA Device Robust mobile DSVA device for treating small volumes (1 to 40 m³) with an exclusive multi-cycle programme for isolators, RABS, BSC and PSM equipment; part of the Phileas® EASY range.
• Phileas One DSVA Device DSVA device covering 10 to 165 m³, focused on volume and mobility, designed for communities, hospitals, retirement homes, nurseries, veterinary, food industry and research laboratories; part of the Phileas® EASY range.
• Phileas 15 DSVA Device Compact high-performing DSVA device (10 to 165 m³) with stable base for tank/silo integration, suitable for high volumes of 20–1000 hL and spaces without electrical outlets; part of the Phileas® EASY range.
• Phileas 285 DSVA Device High-power, high-volume DSVA device (50 to 1665 m³) with pre-programmable autonomous operation requiring no operator presence; part of the Phileas® EASY range.
• Phileas Genius DSVA Device Technology-concentrated DSVA device (0.5 to 5 m³) for autonomous treatment of mini-volumes in pharmaceutical and laboratory industries; part of the Phileas® OPTIMUM range. Used by NHS for hospital isolator 6-log10 spore reduction validation.
• Phileas 75 DSVA Device Precision and mobility-focused DSVA device (10 to 165 m³) offering high treatment capacity with strong autonomy-mobility balance for demanding GMP environments; part of the Phileas® OPTIMUM range.
• Phileas 250 DSVA Device Powerful, precise DSVA device (50 to 800 m³) for demanding industrial environments and high-volume research laboratories; part of the Phileas® OPTIMUM range.
• Phileas Control DSVA Device Safety and control DSVA device for classified GMP environments (up to 300 m³) combining performance, traceability, data integrity, BMS integration and security; part of the Phileas® CONTROL range.
• Phileas Control² DSVA Device Advanced safety and control DSVA device for large-volume GMP environments (up to 800 m³) with integrated process and maximum safety features; part of the Phileas® CONTROL range.
• Phileas Airlock DSVA Device Integrated DSVA device for airlock installation (up to 40 m³ airlocks, up to 160 m³ zones), with diffusion module and H₂O₂ sensor inside, control console and display outside, HVAC integration and door locking; part of the Phileas® INSIDE range.
• Phileas ISO Isolator-Integrated DSVA Device Isolator-integrated DSVA device (30 to 500 L per nozzle) for efficient, easy surface disinfection with complete operator safety; part of the Phileas® INSIDE range.
• Phileasafe Biocide Solution Ready-to-use, broad-spectrum disinfectant solution compliant with EN 17-272 standard, with a 2-year shelf life; the proprietary consumable used with Phileas® devices for airborne surface disinfection.
• O2SAFE 7.4 Biocide Solution Ready-to-use low-concentration (7.4%) hydrogen peroxide biocide compliant with EN 17-272, effective as bactericidal, levuricide, fungicidal and sporicidal agent for clean surfaces in rooms, materials, equipment and food-contact surfaces.
• MyPhileas Traceability Application Standalone traceability and data-integrity application for Phileas devices, enabling remote programming, cycle monitoring and complete documentation of diffusion cycles; audited compliant with GMP Annex 11 and 21 CFR Part 11.
• DSVA Bio-decontamination Service Professional on-site bio-decontamination service where Devea prepares with clients and performs DSVA operations, including 6-log service provisions in large volumes.
• IQ/OQ/PQ Qualification and Personalized Project Service Qualification (IQ, OQ, PQ) services and personalised project support leveraging Devea's ASD experience across pharmaceutical, healthcare and food industry sectors.
• Preventive Maintenance, Warranty and After-Sales Service One-year warranty on Phileas machines plus preventive maintenance and comprehensive after-sales support services.

Quantifiable outcome

• 6-log₁₀ reduction of bacterial spores (Geobacillus stearothermophilus) validated in challenging conditions
• +4 more outcomes

Named customers33 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature3 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• NaobioscoreStrategic or Co-development Partner · 9 July 2025French CDMO certified to GMP standards, specialized in bioprocess development with live viruses and GMOs. Collaborated on BSL-3 ASD validation achieving 6-log10 spores and 4-log10 virus (MVM) reduction. Results presented at PDA 2025 Congress.
• DigisantéminorOthers · 1 January 2024Digital agency responsible for website development and management. Located in Nantes, France. Specialized in digital health and well-being sector.
• ScalewayminorOthersCloud hosting provider for Devea's website infrastructure. Scaleway is a French cloud computing company.
• Genesys (Korea)coreChannel Partner/ Reseller/ DistributorKorean distribution partner managing Devea technology distribution in Korea and broader Asian market. New team member Pierre Guhel introduced to strengthen Asian partner relationships.
• BIOTECHNICA DWC-LLCcoreChannel Partner/ Reseller/ DistributorLocal partner for Maghreb region (Algeria). Represented Devea at Maghreb Pharma tradeshow in Algiers.
• Analytical Control De Mori s.r.l. / Gruppo A De Mori S.p.A.coreChannel Partner/ Reseller/ DistributorItalian partner representing Devea at AFI Rimini tradeshow. Provides sales and support for Italian pharmaceutical market.
• Led Techno | Lab SolutionscoreChannel Partner/ Reseller/ DistributorBelgian partner for Devea technology distribution. Participated in A3P Association event in Liège, Belgium.
• Lilly FrancecoreStrategic or Co-development PartnerCo-authored white paper with Isabelle Hoenen, Senior Advisor Quality at Lilly France, on Automated Airborne Surface Disinfection (ASD) in RABS. Published in La Vague, Issue No. 85.

Scale indicators4 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Ecolab: Ecolab is a global leader in water, hygiene and infection-prevention solutions; its acquisition of Bioquell makes it a broad incumbent competing in pharma and healthcare surface disinfection. Its scale, service network and chemistry portfolio position it as both competitor and potential acquirer of DEVEA.
• STERIS: STERIS is a large global sterilization and infection-prevention company whose VHP (vaporized hydrogen peroxide) systems and sterilization services overlap directly with DEVEA's ASD/DSVA offering in pharma and healthcare. It competes as a broad incumbent with a much larger portfolio, global service network, and direct US sales force.
• Getinge: Getinge is a large medical-technology group with infection-control, sterilization, and pharma processing equipment lines that overlap with DEVEA's end customers. It competes indirectly via broader hospital and pharma sterilization portfolios rather than a focused ASD device.
• Halma plc: Halma is a diversified group of safety and environmental health technology companies, historically including Bioquell. Through its portfolio of healthcare and cleanroom sensor/sterilization businesses it competes and invests across the same infection-prevention and pharma monitoring space as DEVEA.

Direct peers

• Bioquell (Ecolab): Bioquell, now part of Ecolab, is the most direct competitor to DEVEA — offering hydrogen peroxide vapor (HPV) bio-decontamination systems for pharmaceutical, healthcare and life-science customers. It shares the same airborne H2O2 decontamination category, the same enterprise pharma customer base, and a comparable service-plus-consumable revenue model.
• CURIS System: CURIS produces hydrogen peroxide fog decontamination devices used in biosafety labs, pharmaceutical facilities, and healthcare settings. It is a focused ASD competitor comparable in size and product philosophy to DEVEA, though with less European AMM coverage.
• TOMI Environmental Solutions: TOMI markets SteraMist, an ionized hydrogen peroxide (iHP) surface and room decontamination platform, targeting hospitals, life sciences, and food safety. It directly competes with DEVEA in the same airborne H2O2 decontamination category, though with a different delivery mechanism (ionized mist vs. centrifugation micro-droplets).
• Laboratoires Anios (Ecolab): Anios, now part of Ecolab, supplies surface disinfectants and bio-decontamination chemistries used in hospitals and pharmaceutical cleanrooms across Europe. It overlaps with DEVEA on biocide chemistry and healthcare surface disinfection use cases, and shares a strong European regulatory footprint.

Emerging players

• Schülke & Mayr: Schülke supplies surface disinfectants and hygiene products for pharmaceutical, healthcare and food industry customers across Europe. It overlaps with DEVEA on biocide chemistries and on key end-markets, though it does not sell dedicated airborne disinfection devices.

Others

• Contec: Contec manufactures cleanroom consumables, wipes and disinfectant solutions used in pharmaceutical and life-science manufacturing environments that overlap with DEVEA's pharma and healthcare customers. It is an adjacent enabler rather than a direct ASD competitor, but competes for the same contamination-control budget.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCEBzRIlxH2GMVoy_tyC52iQ
• LinkedInlinkedin.com/company/devea-environnement

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DEVEA SAS